PV pharm branch, vendor, cage 0U9U0
Ended Awarded
- Contract number
- SPE2D826F01N5
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $22,541
Award facts
- Contract value 100% obligated
- $22,541.46 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $22,541.46 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on October 20, 2025, with an ultimate completion date of October 21, 2025. This firm fixed-price contract represents a child order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The contract is not set-aside and was competitively awarded. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement, supplying pharmaceutical products and medical supplies to military and veteran healthcare systems, the Defense Health Agency, and the U.S. Coast Guard.
Under this delivery order, AmerisourceBergen will supply pharmaceutical products and medical commodities from its comprehensive portfolio, which includes brand-name and generic medications, vaccines, specialty drugs, and medical devices across multiple therapeutic domains. The parent IDV contract demonstrates the company's capability to fulfill diverse federal medical supply requirements globally, supporting military healthcare programs through a flexible contracting vehicle that enables rapid fulfillment of medical procurement needs. The DLA's Pharmaceutical Prime Vendor Global Program Generation V initiative anticipates multiple regional awards among qualified contractors, positioning AmerisourceBergen as one of several strategic suppliers for the agency's pharmaceutical requirements.
Quick answers
Who was awarded contract SPE2D826F01N5?
SPE2D826F01N5 was awarded to Amerisourcebergen Drug Corp by Medical Supply Chain (Troop Support) on October 20, 2025.
How much is contract SPE2D826F01N5 worth?
The government has obligated $22,541 on SPE2D826F01N5.
Is contract SPE2D826F01N5 an order under another contract?
Yes. SPE2D826F01N5 is a delivery order under SPE2DX22D0069, an indefinite delivery contract.
Was contract SPE2D826F01N5 competed?
The extent of competition for SPE2D826F01N5 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award